Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Biomedtracker
19 Oct 2018
Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.
Trialtrove
By Christine Blazynski, PhD 19 Oct 2018
As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.
Topic Clinical trials
Citeline, Trialtrove
By Laura Runkel 19 Oct 2018
Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.
Medtech Insight
By Elizabeth Orr 18 Oct 2018
Two 510(k) pilots from US FDA indicate the agency's desire for faster, easier clearances. But some observers aren’t sure if they’ll lead to real improvements.
Topic FDA
Pink Sheet
By Michael McCaughan 18 Oct 2018
Treating mandatory wholesale acquisition cost disclosure in TV ads as a major drug pricing reform is close to ludicrous. But the broad approval of the action is an important sign of the continued public image cost of the ads to the drug companies.
Topic Drug approval Drug review
Pink Sheet
By Ian Schofield 18 Oct 2018
Companies wanting to compete in the newly off-patent adalimumab market in England have until Oct. 22 to submit their bids. They will need to offer “competitive prices” if they are to secure the highest share of sales to the national health service. At the same time, NHS trusts and clinical commissioning groups have been warned not to accept discounted interim offers from suppliers keen to get a foot in the door.
Medtech Insight
By David Filmore 18 Oct 2018
A controversial 2016 proposed rule that would have required manufacturers of many class II and class III home-use devices to electronically submit device labeling information to US FDA will not be finalized, the agency affirmed in the Oct. 17 HHS Unified Agenda document. The agency also signaled plans to imminently finalize a broad device classification rule, and other updates.
Topic Medtech
Scrip
By Jessica Merrill 18 Oct 2018
PhRMA unveiled a voluntary policy under which drug makers will provide information in DTC ads about how to access drug prices and cost information. But hours later HHS issued a proposed rule on the same topic, only requiring drug makers to include WAC prices in TV ads.
Topic Drug approval Drug review
Scrip
By Alexandra Shimmings 18 Oct 2018
On the brink of an expanded US approval for asthma, Sanofi/Regeneron’s interleukin-4 receptor blocker Dupixent has produced positive topline Phase III data in a lucrative third indication, rhinosinusitis with nasal polyps.
Topic Influenza virus
Research and Development Strategy Solutions
15 Oct 2018
Marketing Services from Informa Pharma Intelligence connects you to the key decision makers you need to reach. Boasting the most accurate and trusted pharma and medtech intelligence in the industry.
Biomedtracker
12 Oct 2018
Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships, and is now available for you to download – free.
Medtech Insight
12 Oct 2018
The inaugural Medtech Insight Awards took place on September 23 in Philadelphia. It was an exciting evening of celebration, camaraderie and spirit, and the participation and enthusiasm of everyone present helped make the event a rousing success.
Informatics Solutions
09 Oct 2018
Pharma Intelligence Informatic solutions transform how you access information and make critical business decisions, delivering trusted data on your terms, the way you want it.
Topic Strategy
Scrip
03 Oct 2018
The 2015 Scrip Lifetime Achievement Award was given to Sir Gregory Winter, Master of Trinity College, Cambridge (UK). Founder of Cambridge Antibody Technology (acquired by AstraZeneca), Domantis (acquired by GlaxoSmithKline) and Bicycle Therapeutics, he is best known for his pioneering research into humanizing antibodies. His findings led to the development of the first human antibody, Humira (adalimumab), until very recently the world's top-selling drug.
Scrip
By Jo Shorthouse 03 Oct 2018
Biochemist Greg Winter has scientifically contributed to some of the pharmaceutical industry's biggest commercial and therapeutic success stories. He tells Scrip how he feels about being labelled a pioneer and why he is still wary of the boardroom.
Topic Cancer
Pink Sheet
19 Oct 2018
Scrip
18 Oct 2018
Pink Sheet
18 Oct 2018
Scrip
18 Oct 2018
Medtech Insight
18 Oct 2018
Pink Sheet
18 Oct 2018
Scrip
18 Oct 2018
Medtech Insight
18 Oct 2018
Pink Sheet
18 Oct 2018
Scrip
18 Oct 2018
Pink Sheet
18 Oct 2018
Pink Sheet
18 Oct 2018
Scrip
18 Oct 2018
Medtech Insight
18 Oct 2018
Medtech Insight
18 Oct 2018
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
24 Oct 2018 , 08:00 PST
USA
Webinar
31 Oct 2018
Queensland , Australia
Industry conference
05 Nov 2018
Denmark
Industry conference
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date